Choline alleviates cognitive impairment in sleep-deprived young mice via reducing neuroinflammation and altering phospholipidomic profile
Redox Biology,
Год журнала:
2025,
Номер
81, С. 103578 - 103578
Опубликована: Март 1, 2025
Cognitive
impairment
resulting
from
insufficient
sleep
poses
a
significant
public
health
concern,
particularly
in
children.
The
effects
and
mechanisms
of
choline
on
cognitive
caused
by
deprivation
are
unknown.
Chronic
is
induced
young
mice
this
study,
followed
feeding
diet
containing
11.36
g/kg
bitartrate.
Choline
supplementation
significantly
improves
spatial
learning
ability.
Functional
MRI
results
reveal
the
hippocampus
as
key
region
affected
deprivation,
where
notably
preserves
hippocampal
structural
integrity
enhanced
connectivity.
Additionally,
ameliorates
pathological
injury,
reduces
blood-brain
barrier
permeability
serum
brain
injury
biomarkers.
also
inflammation
oxidative
stress
biomarkers,
mitigates
microglial
activation
hippocampus,
which
synaptic
plasticity.
A
finding
changes
phospholipidomic
profile
along
with
function,
total
313
phospholipid
molecules
identified.
increases
levels
sub-classes
(particularly
PC),
strongly
correlated
reduced
neuroinflammation
well
improved
outcomes.
Furthermore,
there
similar
findings
some
such
PC
36:1,
O-33:0,
p-38:3,
PE
36:3,
p-42:4
PS
44:12.
These
highlight
that
alleviates
via
reducing
altering
profile.
This
study
suggests
could
develop
into
functional
food
or
medicine
ingredient
to
prevent
treat
disturbances,
children
adolescents.
Язык: Английский
Cannabinoid agonist WIN55,212-2 prevents scopolamine-induced impairment of spatial memory in rats
European Journal of Pharmacology,
Год журнала:
2025,
Номер
unknown, С. 177612 - 177612
Опубликована: Апрель 1, 2025
Язык: Английский
Synthesis and Pharmacological Characterization of a Novel Cannabinoid Receptor 1 Antagonist
ACS Omega,
Год журнала:
2025,
Номер
unknown
Опубликована: Июнь 2, 2025
Язык: Английский
Cannabinoid agonist WIN55,212-2 prevents scopolamine-induced impairment of spatial memory
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 17, 2024
Abstract
The
endocannabinoid
system
is
involved
in
diverse
processes,
like
learning
and
memory,
governed
by
cholinergic
neurotransmission.
Recent
research
demonstrates
that
a
model
of
dementia
derived
from
basal
forebrain
degeneration,
WIN55,212-2
improves
cognition
through
increased
cortical
choline
levels.
However,
the
effect
cannabinoids
on
deficits
still
under
investigation.
In
this
work,
we
studied
treatment
pharmacological
transient
hypofunction
acute
administration
muscarinic
antagonist,
scopolamine,
spatial,
recognition
aversive
memory
tests.
Scopolamine
induced
impairment
was
observed
three
tests
and,
importantly,
cannabinoid
subchronic
with
low
doses
prevented
deleterious
spatial
when
evaluated
Barnes
maze
test.
Autoradiographic
studies
indicate
that,
following
treatment,
receptor
density
motor
somatosensory
cortices.
layers
I-V
cortex,
activity
receptors
also
increased.
These
results
suggest
WIN55,212-2,
activation
CB
1
receptors,
indirectly
elevates
tone
key
areas
for
preventing
scopolamine
specifically
memory.
This
highlights
importance
crosstalk
between
processes
agonists
might
be
an
alternative
cognitive
associated
dysfunction.
Язык: Английский